
UC Biomed Building Investment: Advancing Research at the University of Coimbra
The Universidade de Coimbra (UC) is preparing to inaugurate its new UC Biomed building in the coming months, marking a significant milestone for the institution's biomedical research and teaching capabilities. According to recent updates, the facility—located at Polo III—has entered its final pha...

Overview of the Health Innovation Award 2026: Promoting Sustainable Solutions in Healthcare
The Health Innovation Award continues its mission in 2026 by spotlighting data-driven projects that advance sustainability across Portugal’s health sector. Launched by Faculdade de Medicina da Universidade de Lisboa, Sanofi, and NTT DATA Portugal, it invites submissions through its dedicated plat...

Commitment to Health Strategies in Portugal: A Pathway Towards Sustainable Change
In advancing health strategies in Portugal, the Ordem dos Farmacêuticos met with Adalberto Campos Fernandes to urge the country to move from promising ideas to concrete implementation of the

European Health Resilience: Strengthening Preparedness Amidst Geopolitical Challenges
EFPIA and Vaccines Europe endorse the European Commission’s Communication titled “Reinforcing Global Health Resilience Amidst Geopolitical Change,” published on 13 May, as a constructive advancement in bolstering European Health Resilience within a fragmented global environment. The statement hig...

SAHPRA SAPC Regulatory Enforcement: Addressing Unregistered GLP-1 and GIP Products
SAHPRA SAPC regulatory enforcement has intensified following the seizure of all GLP-1 and GIP injectable products at iDexis (Pty) Ltd trading as Sentra Pharmacy. An inspection on 11 May 2026 revealed the facility was manufacturing and distributing unregistered medicines containing semaglutide, ti...

Impact of MDR Software Regulations on Medical Device Innovation
MDR software regulations under the EU’s Medical Device Regulation (EU 2017/745) are creating heavy operational and financial pressures, according to a survey of 35 SaMD manufacturers listed in the EUDAMED database. Financial burdens hit 88.6 % of respondents at significant or severe levels, while...















